Malawi vs Mus: HIV-positive TB patients on ART (antiretroviral therapy)
Malawi
100.0%
in 2024
Mus
100.0%
in 2024
Malawi rank
1st
Mus rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malawi
- Mus
How they compare
Malawi currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 4 times across 21 shared years of data; in 2003 it was Mus ahead.
Malawi ranks 1st and Mus ranks 1st of 144 countries.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malawi | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.3% | 67.3% | 32.1% | Mus |
| 2010s | 85.5% | 86.2% | 0.7% | Mus |
| 2020s | 99.4% | 100.0% | 0.6% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malawi or Mus?
- Malawi, at 100.0% against 100.0% in Mus as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malawi and Mus?
- 0.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and Mus?
- 21 years are reported by both, from 2003 to 2024.
- How do Malawi and Mus rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malawi ranks 1st and Mus ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.